45 articles, transcripts, and reports
Abbott (NYSE: ABT) on Friday reported positive data from studies evaluating the safety and effectiveness of its Volt Pulsed Field...
Abbott Laboratories (NYSE: ABT) FY 2026 Other Release
Medical device maker Abbott Laboratories (NYSE: ABT) on Thursday reported a 4% increase in sales for the fourth quarter of FY25. The company also issued…
Abbott Laboratories (NYSE: ABT) Q2 2025 Earnings Call dated Jul. 17, 2025 Corporate Participants: Michael Comilla — Vice President of Investor Relations Robert B. Ford…
Abbott Laboratories (NYSE: ABT) Q3 2025 Earnings Call dated Oct. 15, 2025 Corporate Participants: Mike Comilla — Vice President, Investor Relations Robert B. Ford —…
Abbott Laboratories (NYSE: ABT) on Thursday announced financial results for the second quarter of fiscal 2025, reporting an increase in sales and adjusted profit. The…
Abbott Laboratories (NYSE: ABT) reported its first quarter 2025 earnings results today. Total sales increased 4% year-over-year to $10.35 billion. Organic sales growth was 6.9%.…
Abbott Laboratories (NYSE: ABT) on Wednesday announced financial results for the fourth quarter of 2024, reporting an increase in sales and adjusted profit. Total reported…
Abbott Laboratories (NYSE: ABT) reported third quarter 2024 earnings results today. Total reported sales increased 4.9% year-over-year to $10.6 billion. Organic sales growth was 7.6%.…
Abbott Laboratories (NYSE: ABT) reported second quarter 2024 earnings results today. Net sales increased 4% year-over-year to $10.4 billion. Net earnings decreased 5% to $1.3…
